|

Dapagliflozin (Forxiga) Clinical Trials

2 actively recruiting trials

Pipeline

Phase 4: 2

Top Sponsors

  • University Hospital Tuebingen1
  • National Institute of Cardiology, Warsaw, Poland1

Indications

  • PreDiabetes2
  • Diabetes2
  • Type2diabetes1
  • Heart Disease1
  • Renal Failure1

Other2 trials

Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes
Phase 4
SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.